Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.96 | 12.82 |
| PEG Ratio (TTM) | -4.94 | 1.73 |
| P/S Ratio (TTM) | 1.87 | 2.68 |
| P/B Ratio (TTM) | 0.78 | 1.74 |
| P/FCF Ratio (TTM) | 10.10 | -12.64 |
| Price to 5YR AVG Earnings Ratio | 11.35 | 9.17 |
| Price to 5YR AVG FCF Ratio | 9.33 | 6.04 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.59% | 1.68% |
| ROE (TTM) | 5.35% | 16.43% |
| Net Profit Margin (TTM) | 12.70% | 23.27% |
| ROIC 5YR AVG | 8.07% | 15.12% |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.82% | 40.31% | 15.33% |
| Revenue | 4.49% | 2.86% | -14.09% |
| Net Income | 8.87% | 42.08% | 18.64% |
| Cash Flow | -10.76% | 617.38% | 381.01% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.36 | 6.32 |
| Quick Ratio (TTM) | 0.36 | 6.42 |
| D/E Ratio (TTM) | 0.56 | 1.58 |
| Interest Coverage (TTM) | 0.37 | 0.81 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | N/A | 0.45 |
| LTL to 5YR AVG FCF | 6.34 | 7.83 |
| Shares Outstanding Growth 5YR AVG | 0.04% | 1,894.82% |